pdf

O’Melveny Represents Buyer Group Led by Yunfeng Capital, TF Capital and Tony (Bizuo) Liu in a Going Private Transaction of Cellular Biomedicine Group

8월 14, 2020

 

FOR IMMEDIATE RELEASE

O’Melveny represents a buyer consortium led by Yunfeng Capital, TF Capital and Tony (Bizuo) Liu (“Buyer Group”) in a going private transaction involving Cellular Biomedicine Group, Inc. (Nasdaq:  CBMG).  CBMG develops proprietary cell therapies for the treatment of cancer and degenerative diseases. 

The Buyer Group consists of 16 members, including, among others, Tony (Bizuo) Liu, the CEO of CBMG, certain other members of CBMG management, Yunfeng Capital, TF Capital and other well-known private equity funds. 

Pursuant to a merger agreement dated August 11, 2020, the Buyer Group will acquire all of the outstanding shares of the Company not owned by them at a merger consideration equal to US$19.75 per share, representing aggregate equity value of approximately US$380million.

The O’Melveny team was led by partner Nima Amini, and included counsel Alan Bao and Nolan Shaw, associates Grace Xu, Jhe-yu Su, Qianru Hong, and Hilda Leung, and senior legal consultant Aaron Xin.  In addition, partner Greta Lichtenbaum, of counsel Ted Kassinger and counsel David Ribner advised on CFIUS-related matters, partner Luc Moritz and counsel Billy Abbott advised on tax issues, and partner Courtney Dyer and counsel Courtney Byrd advised on US antitrust issues, and partner Chris Del Rosso advised on employee benefits.

About O’Melveny

It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com or learn more in our firm at-a-glance, year-end highlights, and on LinkedIn, Twitter, Facebook, Instagram, and YouTube.

Contact:

Christopher Rieck
O’Melveny & Myers LLP
+1 212 326 2218
crieck@omm.com

Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com